Trademark: 97516514
Status Date
Thursday, August 10, 2023
Filing Date
Friday, July 22, 2022
Published for Opposition
Tuesday, May 16, 2023
5 Pharmaceutical preparations for the treatment of liver disease and monogenic disease; pharmaceutical preparations for the treatment of metabolic disorders, or central nervous system disorders; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Alport Syndrome; pharmaceutical preparations for the treatment of glomerulonephropathy; pharmaceutical preparations for the treatment of glomerulonephritis
The mark consists of a pathway through a center of a circle, the pathway dividing individual triangles in lighter shading that becomes darker toward the center on the left side of the pathway and darker shading that becomes lighter toward the bottom on the right side of the pathway.
Color is not claimed as a feature of the mark.
Aug 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 11, 2023
Corrected Noa E-Mailed
Aug 10, 2023
Sou Extension 1 Granted
Jul 26, 2023
Sou Extension 1 Filed
Aug 10, 2023
Divisional Processing Complete
Jul 26, 2023
Divisional Request Received
Aug 9, 2023
Case Assigned To Intent To Use Paralegal
Jul 26, 2023
Teas Request To Divide Received
Jul 26, 2023
Sou Teas Extension Received
Jul 11, 2023
Noa E-Mailed - Sou Required From Applicant
May 16, 2023
Official Gazette Publication Confirmation E-Mailed
May 16, 2023
Published For Opposition
Apr 26, 2023
Notification Of Notice Of Publication E-Mailed
Apr 12, 2023
Approved For Pub - Principal Register
Apr 4, 2023
Assigned To Examiner
Aug 16, 2022
Notice Of Design Search Code E-Mailed
Aug 15, 2022
New Application Office Supplied Data Entered
Jul 27, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
